DANIEL LEUNG to Risk Factors
This is a "connection" page, showing publications DANIEL LEUNG has written about Risk Factors.
Connection Strength
0.380
-
Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy. Liver Int. 2023 06; 43(6):1277-1286.
Score: 0.079
-
A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation. Liver Transpl. 2016 11; 22(11):1584-1592.
Score: 0.051
-
Drug-induced liver injury in children. Curr Opin Pediatr. 2015 Oct; 27(5):625-33.
Score: 0.047
-
Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis. J Pediatr. 2015 Oct; 167(4):862-868.e2.
Score: 0.046
-
High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients. Am J Transplant. 2015 Feb; 15(2):535-40.
Score: 0.045
-
Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. World J Gastroenterol. 2014 Aug 28; 20(32):11281-6.
Score: 0.043
-
Estimating risk of prolonged mechanical ventilation after liver transplantation in children: PROVE-ALT score. Pediatr Transplant. 2024 Feb; 28(1):e14623.
Score: 0.020
-
The Multidisciplinary Pediatric Liver Transplant. Curr Probl Surg. 2023 11; 60(11):101377.
Score: 0.020
-
Hepatic Steatosis Is Prevalent Following Orthotopic Liver Transplantation in Children With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):96-103.
Score: 0.015
-
Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):122-127.
Score: 0.014